Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli

BackgroundCellular interactions elicited by Plasmodium falciparum erythrocyte membrane protein antigen 1 (PfEMP1) are brought about by multiple DBL (Duffy binding like), CIDR (cysteine-rich interdomain region) and C2 domain types. Elucidation of the functional and structural characteristics of these domains is contingent on the abundant availability of recombinant protein in a soluble form. A priori prediction of PfEMP1 domains of the 3D7 genome strain, most likely to be expressed in the soluble form in Escherichia coli was computed and proven experimentally.MethodsA computational analysis correlating sequence-dependent features to likelihood for expression in soluble form was computed and predictions were validated by the colony filtration blot method for rapid identification of soluble protein expression in E. coli.ResultsSolubility predictions for all constituent PfEMP1 domains in the decreasing order of their probability to be expressed in a soluble form (% mean solubility) are as follows: ATS (56.7%) > CIDR1α (46.8%) > CIDR2β (42.9%) > DBL2-4γ (31.7%) > DBL2β + C2 (30.6%) > DBL1α (24.9%) > DBL2-7ε (23.1%) > DBL2-5δ (14.8%). The length of the domains does not correlate to their probability for successful expression in the soluble form. Immunoblot analysis probing for soluble protein confirmed the differential in solubility predictions.ConclusionThe acidic terminal segment (ATS) and CIDR α/β domain types are suitable for recombinant expression in E. coli while all DBL subtypes (α, β, γ, δ, ε) are a poor choice for obtaining soluble protein on recombinant expression in E. coli. This study has relevance for researchers pursuing functional and structural studies on PfEMP1 domains.

[1]  M. Wahlgren,et al.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. , 1995, Scandinavian journal of immunology.

[2]  D. Davies,et al.  Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Pär Nordlund,et al.  Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli , 2005, Nature Methods.

[4]  J. Kane,et al.  Properties of recombinant protein-containing inclusion bodies in Escherichia coli. , 1991, Bioprocess technology.

[5]  A. Sahlén,et al.  Identification of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) as the Rosetting Ligand of the Malaria Parasite P. falciparum , 1998, The Journal of experimental medicine.

[6]  G. Dale,et al.  Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. , 1994, Protein engineering.

[7]  Jürgen Pleiss,et al.  How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli , 2005, BMC Genomics.

[8]  H. P. Sørensen,et al.  Advanced genetic strategies for recombinant protein expression in Escherichia coli. , 2005, Journal of biotechnology.

[9]  A. Saul,et al.  Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1 , 2003, Infection and Immunity.

[10]  David E Hill,et al.  High-throughput expression of C. elegans proteins. , 2004, Genome research.

[11]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Qijun Chen,et al.  Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli , 2004, Malaria Journal.

[13]  David L. Wilkinson,et al.  Predicting the Solubility of Recombinant Proteins in Escherichia coli , 1991, Bio/Technology.

[14]  T. Terwilliger,et al.  Engineering and characterization of a superfolder green fluorescent protein , 2006, Nature Biotechnology.

[15]  Hong Zhou,et al.  Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate , 2005, Infection and Immunity.

[16]  Sanjay K. Singh,et al.  Biochemical, Biophysical, and Functional Characterization of Bacterially Expressed and Refolded Receptor Binding Domain ofPlasmodium vivax Duffy-binding Protein* , 2001, The Journal of Biological Chemistry.

[17]  Nirbhay Kumar,et al.  Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. , 2002, European journal of biochemistry.

[18]  Kane Jf,et al.  Properties of recombinant protein-containing inclusion bodies in Escherichia coli. , 1991 .

[19]  B. Gamain,et al.  Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. , 2000, Molecular and biochemical parasitology.

[20]  Joseph D. Smith,et al.  Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. , 2004, Molecular and biochemical parasitology.

[21]  J. Abrams,et al.  Adhesion of Plasmodium Falciparwn‐lnfected Erythroeytes to Human Cells and Seeretion of Cytokines (IL‐1‐β, IL‐1RA, IL‐6, IL‐8, IL‐10, TGFβ, TNFα, G‐CSF, GM‐CSF) , 1995 .